Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
173 Results for "
Target ability
" in MedChemExpress (MCE) Product Catalog:
Products (173)
173 Results for "Target ability" in MCE Product Catalog:
Cat. No.: HY-P10501A
Target:
Research Areas:
Cat. No.: HY-132260
CAS No.: 1607824-64-5
Synonyms: IMGN529; Debio 1562
Research Areas:
Cat. No.: HY-W008003
CAS No.: 615-16-7
Cat. No.: HY-W873634
CAS No.: 1242003-07-1
Synonyms: TRAP-Pr
Research Areas:
TRAP-Pr is a radionuclide conjugate (RDC) that can bind to the radionuclide [68]Ga. RDCs have the ability to specifically target biomolecules and can be used in medical imaging or therapy. TRAP-Pr can be further functionalized with acetone and used in click chemistry CuAAC reactions to conjugate other labeled molecules.
Cat. No.: HY-157512
CAS No.: 2413035-43-3
Target:
Research Areas:
SJF-0661 is a variant of the von Hippel-Lindau (VHL) protein ligand with no targeted degradation ability and can be used as a control reagent for the VHL ubiquitin ligase ligand. SJF-0661 is a variant obtained by inverting the stereocenter of the key hydroxyproline group in the VHL ligand .
Cat. No.: HY-W011118
CAS No.: 23911-26-4
Research Areas:
DTPA anhydride is a bifunctional chelator whose anhydride can react with amino groups in proteins (such as lysine residues) to form stable amide bonds. DTPA anhydride can also bind to radionuclides to synthesize radionuclide-labeled drug conjugates (RDCs). RDCs have the ability to specifically target biomolecules and can be used in medical imaging or therapy.
Cat. No.: HY-178489
Cat. No.: HY-164653
CAS No.: 137076-50-7
Research Areas:
DOTAEt is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy .
Cat. No.: HY-164590
CAS No.: 2256055-98-6
Research Areas:
BCN-NODAGA is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy .
Cat. No.: HY-P10730
CAS No.: 213187-44-1
Research Areas:
DOTA-Lanreotide is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy .
Cat. No.: HY-164594
Research Areas:
TA-DOTA-GA is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy .
Cat. No.: HY-P10501
CAS No.: 2159055-74-8
Target:
Research Areas:
Cat. No.: HY-177921
CAS No.: 3058580-71-2
PL53 is a kind of cycloalkylamine lipid nanoparticles. PL53 exhibits outstanding transfection efficiency both in vitro and in vivo, especially showing strong protein expression ability and potential tissue targeting after intramuscular injection. PL53 can be used for the study of nucleic acid delivery .
Cat. No.: HY-113011R
CAS No.: 1109-28-0
Cat. No.: HY-151207
CAS No.: 2820286-56-2
Target:
Research Areas:
Anticancer agent 81 (Compound 37b3) is an anticancer agent and can induce tumor cell cycle arrest and apoptosis. Anticancer agent 81 can be used as a payload to conjugate with Trastuzumab (HY-P9907) to obtain the antibody–agent conjugate (ADC) T-PBA. T-PBA maintained its mode of target and internalization ability of Trastuzumab .
Cat. No.: HY-169208
CAS No.: 3036376-10-7
Target:
Research Areas:
MerTK-IN-1 (compund 31) is a MerTK inhibitor with in vivo target binding ability .
Cat. No.: HY-164589
CAS No.: 1397275-76-1
Research Areas:
NOPO is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy .
Cat. No.: HY-164599
CAS No.: 2451069-30-8
Research Areas:
TA-DOTA is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy .
Cat. No.: HY-P10731
CAS No.: 935886-72-9
Research Areas:
DOTA-NAPamide is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy .
Cat. No.: HY-164592
CAS No.: 180152-83-4
Research Areas:
DTPA-tetra(tBu)ester is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
